|
2017-09-27 |
2017-09-25 |
V
Verkauf
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
4.228
-8.5%
179,66
759.619 USD
|
4.228
-8.5%
|
179,66
|
759.619 USD
|
|
|
2017-09-27 |
2017-09-25 |
V
Verkauf
|
Wiezorek Jeffrey
SVP Clinical Development
|
5.283
-17.0%
179,66
949.164 USD
|
5.283
-17.0%
|
179,66
|
949.164 USD
|
|
|
2017-09-27 |
2017-09-25 |
V
Verkauf
|
JENKINSON PAUL L
Chief Financial Officer
|
948
-9.1%
179,66
170.321 USD
|
948
-9.1%
|
179,66
|
170.321 USD
|
|
|
2017-09-27 |
2017-09-25 |
V
Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
4.228
-3.4%
179,66
759.619 USD
|
4.228
-3.4%
|
179,66
|
759.619 USD
|
|
|
2017-09-27 |
2017-09-25 |
V
Verkauf
|
Belldegrun Arie
Chairman, President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
26.347
-19.4%
179,66
4.733.605 USD
|
26.347
-19.4%
|
179,66
|
4.733.605 USD
|
|
|
2017-09-27 |
2017-09-25 |
V
Verkauf
|
Kim Helen Susan
EVP, Business Development
|
3.171
-12.8%
179,66
569.714 USD
|
3.171
-12.8%
|
179,66
|
569.714 USD
|
|
|
2017-09-27 |
2017-09-25 |
V
Verkauf
|
Tomasello Shawn
Chief Commercial Officer
|
4.203
-6.4%
179,66
755.127 USD
|
4.203
-6.4%
|
179,66
|
755.127 USD
|
|
|
2017-09-27 |
2017-09-25 |
V
Verkauf
|
Chang David D
EVP, R&D, Chief Medical Off.
|
7.927
-12.1%
179,66
1.424.196 USD
|
7.927
-12.1%
|
179,66
|
1.424.196 USD
|
|
|
2017-08-14 |
2017-08-10 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
5.800
-4.7%
121,03
701.974 USD
|
5.800
-4.7%
|
121,03
|
701.974 USD
|
|
|
2017-08-14 |
2017-08-10 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
9.200
-6.9%
120,52
1.108.784 USD
|
9.200
-6.9%
|
120,52
|
1.108.784 USD
|
|
|
2017-08-14 |
2017-08-10 |
GV
Geplanter Verkauf
|
Kim Helen Susan
EVP, Business Development
|
6.251
-25.1%
120,09
750.683 USD
|
6.251
-25.1%
|
120,09
|
750.683 USD
|
|
|
2017-08-10 |
2017-08-08 |
GV
Geplanter Verkauf
|
Kim Helen Susan
EVP, Business Development
|
13.274
-41.6%
121,37
1.611.065 USD
|
13.274
-41.6%
|
121,37
|
1.611.065 USD
|
|
|
2017-08-10 |
2017-08-08 |
GV
Geplanter Verkauf
|
Kim Helen Susan
EVP, Business Development
|
31.165
-49.4%
120,40
3.752.266 USD
|
31.165
-49.4%
|
120,40
|
3.752.266 USD
|
|
|
2017-08-10 |
2017-08-08 |
GV
Geplanter Verkauf
|
Kim Helen Susan
EVP, Business Development
|
18.936
-23.1%
119,94
2.271.184 USD
|
18.936
-23.1%
|
119,94
|
2.271.184 USD
|
|
|
2017-08-10 |
2017-08-08 |
GV
Geplanter Verkauf
|
Kim Helen Susan
EVP, Business Development
|
3.800
-4.4%
118,61
450.718 USD
|
3.800
-4.4%
|
118,61
|
450.718 USD
|
|
|
2017-08-10 |
2017-08-08 |
GV
Geplanter Verkauf
|
Kim Helen Susan
EVP, Business Development
|
1.700
-1.9%
117,27
199.359 USD
|
1.700
-1.9%
|
117,27
|
199.359 USD
|
|
|
2017-08-10 |
2017-08-08 |
GV
Geplanter Verkauf
|
Kim Helen Susan
EVP, Business Development
|
11.074
-11.2%
115,02
1.273.731 USD
|
11.074
-11.2%
|
115,02
|
1.273.731 USD
|
|
|
2017-08-04 |
2017-08-03 |
GV
Geplanter Verkauf
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
5.131
-9.4%
110,05
564.667 USD
|
5.131
-9.4%
|
110,05
|
564.667 USD
|
|
|
2017-08-04 |
2017-08-03 |
GV
Geplanter Verkauf
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
869
-1.6%
110,10
95.677 USD
|
869
-1.6%
|
110,10
|
95.677 USD
|
|
|
2017-08-03 |
2017-08-01 |
GV
Geplanter Verkauf
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
321
-0.6%
109,35
35.101 USD
|
321
-0.6%
|
109,35
|
35.101 USD
|
|
|
2017-08-03 |
2017-08-01 |
GV
Geplanter Verkauf
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
3.771
-7.0%
108,27
408.286 USD
|
3.771
-7.0%
|
108,27
|
408.286 USD
|
|
|
2017-08-03 |
2017-08-01 |
GV
Geplanter Verkauf
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
5.431
-9.2%
107,58
584.267 USD
|
5.431
-9.2%
|
107,58
|
584.267 USD
|
|
|
2017-08-03 |
2017-08-01 |
GV
Geplanter Verkauf
|
MOORE TIMOTHY L.
EVP, Technical Operations
|
2.477
-4.0%
106,85
264.667 USD
|
2.477
-4.0%
|
106,85
|
264.667 USD
|
|
|
2017-08-01 |
2017-07-31 |
GV
Geplanter Verkauf
|
Kim Helen Susan
EVP, Business Development
|
672
-3.5%
111,60
74.995 USD
|
672
-3.5%
|
111,60
|
74.995 USD
|
|
|
2017-08-01 |
2017-07-31 |
GV
Geplanter Verkauf
|
Kim Helen Susan
EVP, Business Development
|
2.725
-12.4%
110,55
301.249 USD
|
2.725
-12.4%
|
110,55
|
301.249 USD
|
|
|
2017-08-01 |
2017-07-31 |
GV
Geplanter Verkauf
|
Kim Helen Susan
EVP, Business Development
|
7.448
-25.2%
109,74
817.344 USD
|
7.448
-25.2%
|
109,74
|
817.344 USD
|
|
|
2017-08-01 |
2017-07-31 |
GV
Geplanter Verkauf
|
Kim Helen Susan
EVP, Business Development
|
15.804
-34.9%
108,75
1.718.685 USD
|
15.804
-34.9%
|
108,75
|
1.718.685 USD
|
|
|
2017-07-11 |
2017-07-10 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
Führungsperson
|
5.000
-4.1%
105,50
527.500 USD
|
5.000
-4.1%
|
105,50
|
527.500 USD
|
|
|
2017-07-11 |
2017-07-10 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
Führungsperson
|
1.100
-0.9%
102,81
113.091 USD
|
1.100
-0.9%
|
102,81
|
113.091 USD
|
|
|
2017-07-11 |
2017-07-10 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
Führungsperson
|
5.553
-4.3%
102,19
567.461 USD
|
5.553
-4.3%
|
102,19
|
567.461 USD
|
|
|
2017-07-11 |
2017-07-10 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
Führungsperson
|
3.347
-2.5%
101,06
338.248 USD
|
3.347
-2.5%
|
101,06
|
338.248 USD
|
|
|
2017-07-06 |
2017-07-03 |
GV
Geplanter Verkauf
|
Wiezorek Jeffrey
SVP Clinical Development
Führungsperson
|
1.201
-5.4%
104,76
125.817 USD
|
1.201
-5.4%
|
104,76
|
125.817 USD
|
|
|
2017-07-06 |
2017-07-03 |
GV
Geplanter Verkauf
|
Wiezorek Jeffrey
SVP Clinical Development
Führungsperson
|
8.799
-28.3%
104,26
917.384 USD
|
8.799
-28.3%
|
104,26
|
917.384 USD
|
|
|
2017-06-26 |
2017-06-26 |
V
Verkauf
|
WITTE OWEN N.
|
12.500
-14.1%
100,60
1.257.500 USD
|
12.500
-14.1%
|
100,60
|
1.257.500 USD
|
|
|
2017-06-27 |
2017-06-23 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
2.050
-1.8%
101,19
207.440 USD
|
2.050
-1.8%
|
101,19
|
207.440 USD
|
|
|
2017-06-27 |
2017-06-23 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
2.950
-2.5%
100,54
296.593 USD
|
2.950
-2.5%
|
100,54
|
296.593 USD
|
|
|
2017-06-26 |
2017-06-23 |
GV
Geplanter Verkauf
|
WITTE OWEN N.
|
12.500
-12.3%
100,00
1.250.000 USD
|
12.500
-12.3%
|
100,00
|
1.250.000 USD
|
|
|
2017-06-16 |
2017-06-16 |
V
Verkauf
|
CHAMPSI FARAH
|
5.450
-100.0%
88,11
480.200 USD
|
5.450
-100.0%
|
88,11
|
480.200 USD
|
|
|
2017-06-16 |
2017-06-14 |
V
Verkauf
|
CHAMPSI FARAH
|
15.000
-19.1%
90,40
1.356.000 USD
|
15.000
-19.1%
|
90,40
|
1.356.000 USD
|
|
|
2017-06-16 |
2017-06-14 |
V
Verkauf
|
Ruchefsky Steven B
|
20.000
-8.9%
89,48
1.789.574 USD
|
20.000
-8.9%
|
89,48
|
1.789.574 USD
|
|
|
2017-06-12 |
2017-06-09 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
400
-0.3%
91,08
36.432 USD
|
400
-0.3%
|
91,08
|
36.432 USD
|
|
|
2017-06-12 |
2017-06-09 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
1.698
-1.4%
89,76
152.412 USD
|
1.698
-1.4%
|
89,76
|
152.412 USD
|
|
|
2017-06-12 |
2017-06-09 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
4.100
-3.3%
89,09
365.269 USD
|
4.100
-3.3%
|
89,09
|
365.269 USD
|
|
|
2017-06-12 |
2017-06-09 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
2.502
-2.0%
87,80
219.676 USD
|
2.502
-2.0%
|
87,80
|
219.676 USD
|
|
|
2017-06-12 |
2017-06-09 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
900
-0.7%
86,42
77.778 USD
|
900
-0.7%
|
86,42
|
77.778 USD
|
|
|
2017-06-12 |
2017-06-09 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
400
-0.3%
84,81
33.924 USD
|
400
-0.3%
|
84,81
|
33.924 USD
|
|
|
2017-06-09 |
2017-06-08 |
V
Verkauf
|
DOUMANI ROY
|
5.000
-3.2%
84,53
422.634 USD
|
5.000
-3.2%
|
84,53
|
422.634 USD
|
|
|
2017-06-09 |
2017-06-07 |
V
Verkauf
|
DOUMANI ROY
|
10.000
-6.1%
84,46
844.621 USD
|
10.000
-6.1%
|
84,46
|
844.621 USD
|
|
|
2017-06-05 |
2017-06-01 |
GV
Geplanter Verkauf
|
Kim Helen Susan
EVP, Business Development
|
2.400
-11.4%
72,45
173.880 USD
|
2.400
-11.4%
|
72,45
|
173.880 USD
|
|
|
2017-05-10 |
2017-05-10 |
K
Kauf
|
JENKINSON PAUL L
Chief Financial Officer
Führungsperson
|
3.000
+inf%
72,59
217.770 USD
|
3.000
+inf%
|
72,59
|
217.770 USD
|
|
|
2017-05-10 |
2017-05-10 |
GK
Geplanter Kauf
|
JENKINSON PAUL L
Chief Financial Officer
Führungsperson
|
450
+6.4%
72,57
32.657 USD
|
450
+6.4%
|
72,57
|
32.657 USD
|
|
|
2017-05-11 |
2017-05-09 |
K
Kauf
|
Nussbaum Ran
Nicht geschäftsführender Verwaltungsratsmitglied
|
2.632
+inf%
68,94
181.450 USD
|
2.632
+inf%
|
68,94
|
181.450 USD
|
|
|
2017-05-11 |
2017-05-09 |
K
Kauf
|
Nussbaum Ran
Nicht geschäftsführender Verwaltungsratsmitglied
|
1.029
+inf%
69,17
71.176 USD
|
1.029
+inf%
|
69,17
|
71.176 USD
|
|
|
2017-05-11 |
2017-05-09 |
K
Kauf
|
Nussbaum Ran
Nicht geschäftsführender Verwaltungsratsmitglied
|
2.651
+inf%
69,17
183.370 USD
|
2.651
+inf%
|
69,17
|
183.370 USD
|
|
|
2017-05-11 |
2017-05-09 |
K
Kauf
|
Nussbaum Ran
Nicht geschäftsführender Verwaltungsratsmitglied
|
3.520
+inf%
69,17
243.478 USD
|
3.520
+inf%
|
69,17
|
243.478 USD
|
|
|
2017-05-10 |
2017-05-09 |
K
Kauf
|
Ruchefsky Steven B
Nicht geschäftsführender Verwaltungsratsmitglied
|
1.400
+0.6%
69,50
97.300 USD
|
1.400
+0.6%
|
69,50
|
97.300 USD
|
|
|
2017-05-09 |
2017-05-09 |
K
Kauf
|
Belldegrun Arie
Chairman, President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
17.000
+24.8%
68,57
1.165.690 USD
|
17.000
+24.8%
|
68,57
|
1.165.690 USD
|
|
|
2017-05-09 |
2017-05-09 |
K
Kauf
|
BONDERMAN DAVID
Nicht geschäftsführender Verwaltungsratsmitglied
|
3.815
+0.2%
70,15
267.622 USD
|
3.815
+0.2%
|
70,15
|
267.622 USD
|
|
|
2017-05-09 |
2017-05-09 |
K
Kauf
|
BONDERMAN DAVID
Nicht geschäftsführender Verwaltungsratsmitglied
|
46.185
+2.0%
68,84
3.179.375 USD
|
46.185
+2.0%
|
68,84
|
3.179.375 USD
|
|
|
2017-05-03 |
2017-05-01 |
GV
Geplanter Verkauf
|
Chang David D
EVP, R&D, Chief Medical Off.
Führungsperson
|
300
-0.6%
83,36
25.008 USD
|
300
-0.6%
|
83,36
|
25.008 USD
|
|
|
2017-05-03 |
2017-05-01 |
GV
Geplanter Verkauf
|
Chang David D
EVP, R&D, Chief Medical Off.
Führungsperson
|
5.905
-10.5%
82,60
487.753 USD
|
5.905
-10.5%
|
82,60
|
487.753 USD
|
|
|
2017-05-03 |
2017-05-01 |
GV
Geplanter Verkauf
|
Chang David D
EVP, R&D, Chief Medical Off.
Führungsperson
|
13.795
-19.7%
81,84
1.128.983 USD
|
13.795
-19.7%
|
81,84
|
1.128.983 USD
|
|
|
2017-05-03 |
2017-05-01 |
GV
Geplanter Verkauf
|
Kim Helen Susan
EVP, Business Development
Führungsperson
|
2.400
-11.4%
82,12
197.088 USD
|
2.400
-11.4%
|
82,12
|
197.088 USD
|
|
|
2017-05-01 |
2017-04-28 |
V
Verkauf
|
CHAMPSI FARAH
Nicht geschäftsführender Verwaltungsratsmitglied
|
2.617
-34.5%
82,59
216.138 USD
|
2.617
-34.5%
|
82,59
|
216.138 USD
|
|
|
2017-05-01 |
2017-04-27 |
V
Verkauf
|
CHAMPSI FARAH
Nicht geschäftsführender Verwaltungsratsmitglied
|
16.551
-68.6%
82,77
1.369.926 USD
|
16.551
-68.6%
|
82,77
|
1.369.926 USD
|
|
|
2017-04-26 |
2017-04-26 |
V
Verkauf
|
CHAMPSI FARAH
|
200
-0.8%
83,06
16.612 USD
|
200
-0.8%
|
83,06
|
16.612 USD
|
|
|
2017-04-26 |
2017-04-26 |
V
Verkauf
|
CHAMPSI FARAH
|
51.112
-67.8%
82,72
4.227.985 USD
|
51.112
-67.8%
|
82,72
|
4.227.985 USD
|
|
|
2017-04-27 |
2017-04-25 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
3.742
-3.1%
82,87
310.100 USD
|
3.742
-3.1%
|
82,87
|
310.100 USD
|
|
|
2017-04-27 |
2017-04-25 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
5.545
-4.4%
82,14
455.466 USD
|
5.545
-4.4%
|
82,14
|
455.466 USD
|
|
|
2017-04-27 |
2017-04-25 |
GV
Geplanter Verkauf
|
BUTITTA CYNTHIA M
Chief Operating Officer
|
5.713
-4.3%
80,89
462.125 USD
|
5.713
-4.3%
|
80,89
|
462.125 USD
|
|
|
2017-04-26 |
2017-04-25 |
V
Verkauf
|
CHAMPSI FARAH
|
15.316
-16.9%
83,29
1.275.670 USD
|
15.316
-16.9%
|
83,29
|
1.275.670 USD
|
|
|
2017-04-26 |
2017-04-25 |
V
Verkauf
|
CHAMPSI FARAH
|
31.467
-25.7%
82,56
2.597.916 USD
|
31.467
-25.7%
|
82,56
|
2.597.916 USD
|
|
|
2017-04-26 |
2017-04-24 |
V
Verkauf
|
CHAMPSI FARAH
|
25.818
-17.4%
82,34
2.125.854 USD
|
25.818
-17.4%
|
82,34
|
2.125.854 USD
|
|
|
2017-04-17 |
2017-04-17 |
V
Verkauf
|
CHAMPSI FARAH
|
100
-0.1%
83,06
8.306 USD
|
100
-0.1%
|
83,06
|
8.306 USD
|
|
|
2017-04-17 |
2017-04-17 |
V
Verkauf
|
CHAMPSI FARAH
|
43.001
-22.5%
82,48
3.546.722 USD
|
43.001
-22.5%
|
82,48
|
3.546.722 USD
|
|
